Human recombinant antibodies or fragments thereof having specificity for the β2-glycoprotein I (β2GPI), pharmaceutical compositions containing same and use thereof in a method for treating or preventing thrombus formation and fetal loss in a patient affected by antiphospholipid syndrome (APS).